TP53 and neoplasm: Similarly, miR‐144 directly targets TP53‐inducible glycolysis and apoptosis regulator (TIGAR) and activates autophagic flux, all of which results in the inhibition of ESCC progression, colony formation, and invasion, and promotion of tumor cell death [56].